The Journal of Pain
Volume 12, Issue 1 , Pages 141-152 , January 2011

Topical Application of Compound Ibuprofen Suppresses Pain by Inhibiting Sensory Neuron Hyperexcitability and Neuroinflammation in a Rat Model of Intervertebral Foramen Inflammation

Received 30 March 2010 ,Revised 4 June 2010 ,Accepted 15 June 2010.

References 

  1. Abbadie C. Chemokines, chemokine receptors and pain. Trends Immunol. 2005;26:529–534
  2. Amaya F, Samad TA, Barrett L, Broom DC, Woolf CJ. Periganglionic inflammation elicits a distally radiating pain hypersensitivity by promoting COX-2 induction in the dorsal root ganglion. Pain. 2009;142:59–67
  3. Bhui K, Prasad S, George J, Shukla Y. Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett. 2009;282:167–176
  4. Brisby H, Olmarker K, Larsson K, Nutu M, Rydevik B. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J. 2002;11:62–66
  5. Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain. 2000;88:239–248
  6. Cummins TR, Sheets PL, Waxman SG. The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain. 2007;131:243–257
  7. Devor M. The Pathology of Damaged Peripheral Nerves: Textbook of Pain. 3rd ed.. London, UK: Churchill Livingstone; 1994;
  8. Dong XW, Goregoaker S, Engler H, Zhou X, Mark L, Crona J, et al. Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats. Neuroscience. 2007;146:812–821
  9. Fitzhugh DJ, Shan S, Dewhirst MW, Hale LP. Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin Immunol. 2008;128:66–74
  10. Galer BS, Rowbotham M, Perander J, Devers A, Friedman E. Topical diclofenac patch relieves minor sports injury pain: Results of a multicenter controlled clinical trial. J Pain Symptom Manage. 2000;19:287–294
  11. Gilmore TD. Introduction to NF-kappaB: Players, pathways, perspectives. Oncogene. 2006;25:6680–6684
  12. Gould HJ, England JD, Soignier RD, Nolan P, Minor LD, Liu ZP, et al. Ibuprofen blocks changes in Nav 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat. J Pain. 2004;5:270–280
  13. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–2224
  14. Heyneman CA, Rhodes RS. Glucosamine for osteoarthritis: Cure or conundrum?. Ann Pharmacother. 1998;32:602–603
  15. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: A comparison. Drugs. 2000;60:555–574
  16. Hong H, Park YK, Choi MS, Ryu NH, Song DK, Suh SI, et al. Differential down-regulation of COX-2 and MMP-13 in human skin fibroblasts by glucosamine-hydrochloride. J Dermatol Sci. 2009;56:43–50
  17. Huang ZJ, Song XJ. Differing alterations of sodium currents in small dorsal root ganglion neurons after ganglion compression and peripheral nerve injury. Mol Pain. 2008;4:20
  18. Joshi SK, Mikusa JP, Hernandez G, Baker S, Shieh CC, Neelands T, et al. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states. Pain. 2006;123:75–82
  19. Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C. Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc Natl Acad Sci U S A. 1999;96:9409–9414
  20. Kim YH, Kim DH, Lim H, Baek DY, Shin HK, Kim JK. The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biol Pharm Bull. 2009;32:651–656
  21. Lai J, Gold MS, Kim CS, Bian D, Ossipov MH, Hunter JC, et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain. 2002;95:143–152
  22. Ma C, Greenquist KW, Lamotte RH. Inflammatory mediators enhance the excitability of chronically compressed dorsal root ganglion neurons. J Neurophysiol. 2006;95:2098–2107
  23. Mattson MP, Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest. 2001;107:247–254
  24. McCormack K, Kidd BL, Morris V. Assay of topically administered ibuprofen using a model of post-injury hypersensitivity. A randomised, double-blind, placebo-controlled study. Eur J Clin Pharmacol. 2000;56:459–462
  25. Mendis E, Kim MM, Rajapakse N, Kim SK. Sulfated glucosamine inhibits oxidation of biomolecules in cells via a mechanism involving intracellular free radical scavenging. Eur J Pharmacol. 2008;579:74–85
  26. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ. 1998;316:333–338
  27. Myers RR, Campana WM, Shubayev VI. The role of neuroinflammation in neuropathic pain: Mechanisms and therapeutic targets. Drug Discov Today. 2006;11:8–20
  28. Neumann M, Naumann M. Beyond IkappaBs: Alternative regulation of NF-kappaB activity. FASEB J. 2007;21:2642–2654
  29. Niederberger E, Geisslinger G. The IKK-NF-kappaB pathway: A source for novel molecular drug targets in pain therapy?. FASEB J. 2008;22:3432–3442
  30. Onken JE, Greer PK, Calingaert B, Hale LP. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin Immunol. 2008;126:345–352
  31. Rajapakse N, Mendis E, Kim MM, Kim SK. Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells. Bioorg Med Chem. 2007;15:4891–4896
  32. Rogers M, Tang L, Madge DJ, Stevens EB. The role of sodium channels in neuropathic pain. Semin Cell Dev Biol. 2006;17:571–581
  33. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev. 2003;55:1–20
  34. Schmelz M, Kress M. Topical acetylsalicylate attenuates capsaicin induced pain, flare and allodynia but not thermal hyperalgesia. Neurosci Lett. 1996;214:72–74
  35. Scholz J, Woolf CJ. The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci. 2007;10:1361–1368
  36. Secor ER, Carson WF, Singh A, Pensa M, Guernsey LA, Schramm CM, et al. Oral bromelain attenuates inflammation in an ovalbumin-induced murine model of asthma. Evid Based Complement Alternat Med. 2008;5:61–69
  37. Sen O, Aydin MV, Bagdatoglu C, Ertorer ME, Bolat FA, Yalcin O, et al. Can E-selectin be a reliable marker of inflammation in lumbar disc disease?. Neurosurg Rev. 2005;28:214–217
  38. Song XJ, Rupert RL. Central projections of spinal receptors. In:  Hill M editors. Principles and Practice of Chiropractic, 3rd ed. New York, NY: Scott Haldeman; 2005;p. 269–273
  39. Song XJ, Xu DS, Vizcarra C, Rupert RL. Onset and recovery of hyperalgesia and hyperexcitability of sensory neurons following intervertebral foramen volume reduction and restoration. J Manipulative Physiol Ther. 2003;26:426–436
  40. Song XJ, Zhang JM, Hu SJ, LaMotte RH. Somata of nerve-injured sensory neurons exhibit enhanced responses to inflammatory mediators. Pain. 2003;104:701–709
  41. Song XJ, Gan Q, Wang ZB, Rupert RL. Lumbar intervertebral foramen inflammation-induced hyperalgesia and hyperexcitability of sensory neurons in the rat. FASEB J:18: PART II A1324 (860.14). 2004;
  42. Song XJ, Wang ZB, Gan Q, Walters ET. cAMP and cGMP contribute to sensory neuron hyperexcitability and hyperalgesia in rats with dorsal root ganglia compression. J Neurophysiol. 2006;95:479–492
  43. Song XJ, Hu SJ, Greenquist KW, Zhang JM, LaMotte RH. Mechanical and thermal hyperalgesia and ectopic neuronal discharge after chronic compression of dorsal root ganglia. J Neurophysiol. 1999;82:3347–3358
  44. Song XJ, Vizcarra C, Xu DS, Rupert RL, Wong ZN. Hyperalgesia and neural excitability following injuries to central and peripheral branches of axons and somata of dorsal root ganglion neurons. J Neurophysiol. 2003;89:2185–2193
  45. Song XJ, Gan Q, Cao JL, Wang ZB, Rupert RL. Spinal manipulation reduces pain and hyperalgesia after lumbar intervertebral foramen inflammation in the rat. J Manipulative Physiol Ther. 2006;29:5–13
  46. Song XS, Huang ZJ, Song XJ. Thiamine suppresses thermal hyperalgesia, inhibits hyperexcitability, and lessens alterations of sodium currents in injured, dorsal root ganglion neurons in rats. Anesthesiology. 2009;110:387–400
  47. Steen KH, Wegner H, Meller ST. Analgesic profile of peroral and topical ketoprofen upon low pH-induced muscle pain. Pain. 2001;93:23–33
  48. Tan ZY, Donnelly DF, LaMotte RH. Effects of a chronic compression of the dorsal root ganglion on voltage-gated Na+ and K+ currents in cutaneous afferent neurons. J Neurophysiol. 2006;95:1115–1123
  49. Tegeder I, Muth-Selbach U, Lotsch J, Rusing G, Oelkers R, Brune K, et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther. 1999;65:357–368
  50. Vaile JH, Davis P. Topical NSAIDs for musculoskeletal conditions. A review of the literature. Drugs. 1998;56:783–799
  51. Walsh AJ, O'Neill CW, Lotz JC. Glucosamine HCl alters production of inflammatory mediators by rat intervertebral disc cells in vitro. Spine J. 2007;7:601–608
  52. Wang JG, Strong JA, Xie W, Zhang JM. Local inflammation in rat dorsal root ganglion alters excitability and ion currents in small-diameter sensory neurons. Anesthesiology. 2007;107:322–332
  53. Wang ZB, Gan Q, Rupert RL, Zeng YM, Song XJ. Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury. Pain. 2005;114:266–277
  54. Whitefield M, O'Kane CJ, Anderson S. Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: A randomized, double-blind study. J Clin Pharm Ther. 2002;27:409–417
  55. Woolf CJ, Ma Q. Nociceptors–noxious stimulus detectors. Neuron. 2007;55:353–364
  56. Yomogida S, Hua J, Sakamoto K, Nagaoka I. Glucosamine suppresses interleukin-8 production and ICAM-1 expression by TNF-alpha-stimulated human colonic epithelial HT-29 cells. Int J Mol Med. 2008;22:205–211

 Supported by Parker Research Foundation (PCCRF-BSR0905), CPII (CPII-XJS0809), and National Institute of Health (NIH-1R43AT004933-01).

PII: S1526-5900(10)00582-1

doi: 10.1016/j.jpain.2010.06.008

The Journal of Pain
Volume 12, Issue 1 , Pages 141-152 , January 2011

Article Tools

* Image Usage & Resolution